#United States #St. Petersburg #Longevity Research #Attilio #Laura Carstensen

Dr. Laura Carstensen Joins Attilio as Co-Chairman

Attilio, a leading human-powered AI life optimization platform, recently announced the appointment of Dr. Laura Carstensen as Co-Chairman. Carstensen, renowned as the founding director of the Stanford Center on Longevity, has been at the forefront of longevity research for nearly two decades. Her deep understanding of aging and emotional well-being is set to play a significant role in shaping Attilio's focus on enhancing quality of life for its members.

For almost 40 years, Dr. Carstensen has been a professor at Stanford University and has built a remarkable career around studying the effects of longevity on happiness and emotional health. Her notable work includes the development of socioemotional selectivity theory, which proposes that as people age, they tend to prioritize emotionally meaningful experiences over less significant ones. This groundbreaking theory, along with her New Map of Life framework, underpins Attilio's innovative approach to aging and lifestyle optimization.

In her new role, Carstensen collaborates with Dr. Eric Verdin, President of the Buck Institute for Research on Aging, and is committed to ensuring that the insights gleaned from scientific research genuinely inform the strategies and tools provided by Attilio. With the growing recognition of longevity as an essential area of study, her presence is expected to significantly enhance the company's credibility in this field.

Dr. Carstensen's expertise will guide how Attilio educates its members about aging, focusing on the positive aspects of growing older, which aligns with the company’s mission to democratize access to a quality lifespan of over 100 years for the vast majority of the U.S. population.

Attilio's Health Optimization Index™ will benefit from Carstensen’s input, as it allows members to track their progress throughout their journey toward health and wellness. The company's innovative approach operates under a Conflict-Free Standards™ policy, meaning that there are no hidden commissions or self-serving practices that could compromise the integrity of the information they provide.

Furthermore, Dr. Carstensen will headline Attilio's inaugural Longevity Event, taking place from October 29 to 30, 2026, at Stanford University and the Buck Institute. This event promises to bring together prestigious professionals in the field, including Dr. Robert Waldinger from Harvard Medical School, and Dr. Dean Ornish. The conference will aim to delve deeper into longevity research and promote collaborative discussions that could shape future studies and applications in the field.

"Laura built this field before the rest of us caught up to her," remarked Paul A. Pagnato, CEO and Founder of Attilio. His sentiment underscores the immense respect for Carstensen's contributions to longevity studies and the excitement surrounding her new position.

By merging cutting-edge research with real-world applications, Attilio aims to set the stage for a paradigm shift in how society approaches aging. With Dr. Carstensen onboard, there is significant optimism about the future direction and impact of their efforts.

For more information about Attilio and its mission, visit www.attilio.com.

In conclusion, the collaboration between Dr. Carstensen and Attilio is poised to lead to significant advancements in longevity science, potentially altering the way individuals perceive aging, health, and overall well-being. This partnership marks an important milestone in the ongoing journey toward maximizing the human lifespan in a meaningful way.